Health Care: Drugs

Novavax Inc (NVAX: NASDAQ)

$4.42 -0.06 | -1.34%
09/19/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 20.92M 22.08M 14.69M 343.00K
Cost of Sales 5.12M 13.04M 5.07M 0.00
Gross Operating Profit 15.79M 9.03M 9.62M 343.00K
Selling, General, and Administrative Expenses 14.82M 10.99M 11.38M 10.80M
Research & Development 50.31M 26.06M 17.88M 28.03M
Operating Income before D & A (EBITDA) -49.34M -28.02M -19.65M -38.49M
Depreciation & Amortization 3.10M 1.65M 1.93M 1.62M
Interest Income 187.00K 165.00K 136.00K 189.00K
Other Income - Net 449.00K 1.02M 2.50M 2.16M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -51.80M -28.48M -18.94M -37.77M
Interest Expense 160.00K 32.00K 9.00K 9.00K
Pre-Tax Income -51.96M -28.51M -18.95M -37.78M
Income Taxes 25.00K 0.00 412.00K -450.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -51.98M -28.51M -19.36M -35.71M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -51.98M -28.51M -19.36M -35.71M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -51.98M -28.51M -19.36M -35.71M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-51.98M -28.51M -19.36M -35.71M
Preferred Dividends
Net Income Available To Common -51.98M -28.51M -19.36M -35.71M
Basic EPS from Continuing Ops. -0.31 -0.22 -0.17 -0.34
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.31 -0.22 -0.17 -0.34
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.31 -0.22 -0.17 -0.34
Basic Normalized Net Income/Share -0.31 -0.22 -0.17 -0.34
EPS fr Continuing Ops. -0.31 -0.22 -0.17 -0.34
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.31 -0.22 -0.17 -0.34
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.31 -0.22 -0.17 -0.34
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.31 -0.22 -0.17 -0.34
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVAX

Latest NVAX Headlines from TheStreet

More Financial News for NVAX

Press Releases for NVAX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter